ClinicalTrials.gg

Program

Saline Solution

Also written as “0.9% NaCl”, “Saline nasal spray” and “saline solution”.

Its studies are mostly in Conjunctivitis, Allergic · Corneal Edema · Fatigue · Amyloidosis · Bronchiolitis, led by 2 companies.

Furthest: no phase, since Jun 25, 20132 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Eye-yon Medical10 open or runningno phasesince Jun 25, 2013Jun 25, 2013none ahead
UVLrx Therapeutics10 open or runningno phasesince Jan 8, 2016Jan 8, 2016none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 25, 2013First study: no phase study in Corneal EdemaNew to Eye-yon MedicalEye-yon Medical · NCT01890252 · 9 enrolled · Israel
  2. Jan 8, 2016UVLrx Therapeutics's first study: no phase study in FatigueNew to UVLrx TherapeuticsUVLrx Therapeutics · NCT02785133 · 3,063 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT02785133Fatigue · United States–CompletedUVLrx TherapeuticsOct 20163,063
NCT01890252Corneal Edema · Israel–CompletedEye-yon MedicalJan 31, 20149

How it is read

Names in the registry

  • “0.9% NaCl”, 1 entry
  • “Saline nasal spray”, 1 entry
  • “saline solution”, 1 entry
  • “Normal Saline Solution”, 1 entry
  • “Sterile Normal Saline (0.9% NaCl)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
Saline Solution (Eye-yon Medical): development program | ClinicalTrials.gg